We are live on ! Find out more
VINCU

Vincerx Pharma, Inc. Unit
VINCU

Delisted

VINCU was delisted on the 25th of March, 2021.

Back to rankings

0 hedge funds and large institutions have $0 invested in Vincerx Pharma, Inc. Unit in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 2 → 0 (-2)

100% less capital invested

Capital invested by funds: $8.11M → $0 (-$8.11M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
–
Holders Change
-2
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BC
Boxer Capital
California
-$8.1M
2
UBS Group
UBS Group
Switzerland
-$7K

VINCU Hedge Fund Activity: Q2 2021 in Review

0 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Vincerx Pharma, Inc. Unit (VINCU) for Q2 2021, worth a combined $0 — down 100% from $8.11M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of VINCU and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Boxer Capital, exiting entirely with an estimated $8.1M sold.

  • 0 institutional investors held Vincerx Pharma, Inc. Unit (VINCU) as of Q2 2021, down from 2 in Q1 2021.
  • Funds reported $0 of Vincerx Pharma, Inc. Unit stock for Q2 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Vincerx Pharma, Inc. Unit positions in Q2 2021 and 2 closed out, a net change of -2 holders.
  • The largest Vincerx Pharma, Inc. Unit seller in Q2 2021 was Boxer Capital, an estimated $8.1M sold.

Based on aggregated 13F filings for Q2 2021.